Journal of Clinical Endocrinology & Metabolism, Vol 78, 1028-1033, Copyright © 1994 by Endocrine Society

ARTICLES

Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine

B Biondi, S Fazio, C Carella, D Sabatini, G Amato, A Cittadini, A Bellastella, G Lombardi and L Sacca
Department of Internal Medicine, Federico II University Medical School, Naples, Italy.

Several symptoms and signs of hyperthyroidism are frequently shared by patients receiving L-T4 suppressive therapy. The aim of this study was to evaluate whether a beta-adrenergic blocking drug could reduce the severity of these symptoms and signs in these patients, as previously reported in patients with hyperthyroidism. Eleven patients (mean age, 42 +/- 11 yr; 10 females and one male) affected with differentiated thyroid carcinoma or nontoxic goiter were selected from a more numerous group of patients receiving suppressive therapy based on the presence of palpitations, increased heart rate, left ventricular systolic function, and other symptoms mimicking exaggerated beta-adrenergic activity. In these patients the cardioselective beta-blocking drug bisoprolol was added to the L-T4 suppressive therapy at a dose of 2.5-5 mg/day. Blood samples were collected for the determination of thyroid hormones and TSH concentration during L-T4 therapy and after 3 and 6 months of associated L-T4 plus bisoprolol therapy. Cardiac function was assessed by clinical evaluation, standard and Holter electrocardiogram, as well as one- and two-dimensional echocardiography. Furthermore, we applied the symptom-rating scale previously used by Klein et al. in hyperthyroid patients to assess the quality of life in our group of patients. Our findings show that the addition of bisoprolol to L-T4 suppressive therapy produces a normalization of heart rate, which was significantly increased during TSH suppressive therapy, and the disappearance of atrial arrhythmias with considerable reduction of palpitations. Furthermore, bisoprolol produced an effective improvement in measures of the hyperthyroid symptom scale, with significant reduction of the mean score. The echocardiographic data showed an increased left ventricular mass index with significantly enhanced systolic function at the basal evaluation. After 6 months of combined L- T4 plus bisoprolol therapy, left ventricular mass index normalized, and the indices of left ventricular systolic function were reduced, with a tendency to normalize. Further studies conducted on a larger series of patients are required to verify the long term implications of cardiac parameter variations on cardiovascular morbidity and mortality. Our results, however, show that the addition of bisoprolol to L-T4 suppressive therapy improves the quality of life in those patients with clinical features of enhanced adrenergic activity.

This article has been cited by other articles:

				B. Biondi and D. S. Cooper The Clinical Significance of Subclinical Thyroid Dysfunction Endocr. Rev., February 1, 2008; 29(1): 76 - 131. [Abstract] [Full Text] [PDF]

				H. C. Hoftijzer, K. A. Heemstra, E. P. M. Corssmit, A. A. van der Klaauw, J. A. Romijn, and J. W. A. Smit Quality of Life in Cured Patients with Differentiated Thyroid Carcinoma J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 200 - 203. [Abstract] [Full Text] [PDF]

				J. W. A. Smit, C. F. A. Eustatia-Rutten, E. P. M. Corssmit, A. M. Pereira, M. Frolich, G. B. Bleeker, E. R. Holman, E. E. van der Wall, J. A. Romijn, and J. J. Bax Reversible Diastolic Dysfunction after Long-Term Exogenous Subclinical Hyperthyroidism: A Randomized, Placebo-Controlled Study J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6041 - 6047. [Abstract] [Full Text] [PDF]

				K Boelaert and J A Franklyn Thyroid hormone in health and disease J. Endocrinol., October 1, 2005; 187(1): 1 - 15. [Abstract] [Full Text] [PDF]

				G. J. Kahaly and W. H. Dillmann Thyroid Hormone Action in the Heart Endocr. Rev., August 1, 2005; 26(5): 704 - 728. [Abstract] [Full Text] [PDF]

				M. Casu, C. Cappi, V. Patrone, E. Repetto, M. Giusti, F. Minuto, and G. Murialdo Sympatho-vagal control of heart rate variability in patients treated with suppressive doses of L-thyroxine for thyroid cancer Eur. J. Endocrinol., June 1, 2005; 152(6): 819 - 824. [Abstract] [Full Text] [PDF]

				B. Biondi, E. A. Palmieri, M. Klain, M. Schlumberger, S. Filetti, and G. Lombardi Subclinical hyperthyroidism: clinical features and treatment options Eur. J. Endocrinol., January 1, 2005; 152(1): 1 - 9. [Abstract] [Full Text] [PDF]

				E H Hoogendoorn, M den Heijer, A P J van Dijk, and A R Hermus Subclinical hyperthyroidism: to treat or not to treat? Postgrad. Med. J., July 1, 2004; 80(945): 394 - 398. [Abstract] [Full Text] [PDF]

				S. Fazio, E. A. Palmieri, G. Lombardi, and B. Biondi Effects of Thyroid Hormone on the Cardiovascular System Recent Prog. Horm. Res., January 1, 2004; 59(1): 31 - 50. [Abstract] [Full Text]

				M. P Vanderpump and J. A Franklyn Thyroid function tests and hypothyroidism: Restoring serum TSH to reference range should be goal of replacement BMJ, May 15, 2003; 326(7398): 1086 - 1087. [Full Text]

				J. A. Sgarbi, F. G. Villaca, B. Garbeline, H. E. Villar, and J. H. Romaldini The Effects of Early Antithyroid Therapy for Endogenous Subclinical Hyperthyroidism in Clinical and Heart Abnormalities J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1672 - 1677. [Abstract] [Full Text] [PDF]

				B. Biondi, E. A. Palmieri, G. Lombardi, and S. Fazio Effects of Subclinical Thyroid Dysfunction on the Heart Ann Intern Med, December 3, 2002; 137(11): 904 - 914. [Abstract] [Full Text] [PDF]

				I. Klein and K. Ojamaa Thyroid Hormone and the Cardiovascular System N. Engl. J. Med., February 15, 2001; 344(7): 501 - 509. [Full Text] [PDF]

				A C Al-Abadi Subclinical thyrotoxicosis Postgrad. Med. J., January 1, 2001; 77(903): 29 - 29. [Full Text]

				B. Biondi, E. A. Palmieri, S. Fazio, C. Cosco, M. Nocera, L. Saccà, S. Filetti, G. Lombardi, and F. Perticone Endogenous Subclinical Hyperthyroidism Affects Quality of Life and Cardiac Morphology and Function in Young and Middle-Aged Patients J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4701 - 4705. [Abstract] [Full Text]

				P. W. Ladenson, P. A. Singer, K. B. Ain, N. Bagchi, S. T. Bigos, E. G. Levy, S. A. Smith, and G. H. Daniels American Thyroid Association Guidelines for Detection of Thyroid Dysfunction Arch Intern Med, June 12, 2000; 160(11): 1573 - 1575. [Abstract] [Full Text] [PDF]

				G. J. Canaris, N. R. Manowitz, G. Mayor, and E. C. Ridgway The Colorado Thyroid Disease Prevalence Study Arch Intern Med, February 28, 2000; 160(4): 526 - 534. [Abstract] [Full Text] [PDF]

				G. J. Kahaly, S. Wagner, J. Nieswandt, S. Mohr-Kahaly, and T. J. Ryan Stress Echocardiography in Hyperthyroidism J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2308 - 2313. [Abstract] [Full Text]

				G. J. Kahaly, J. Nieswandt, S. Wagner, J. Schlegel, S. Mohr-Kahaly, and G. Hommel Ineffective Cardiorespiratory Function in Hyperthyroidism J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4075 - 4078. [Abstract] [Full Text]

				B. Biondi, S. Fazio, F. Coltorti, E. A. Palmieri, C. Carella, G. Lombardi, and L. Saccà Reentrant Atrioventricular Nodal Tachycardia Induced by Levothyroxine J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2643 - 2645. [Full Text]

				R. A. Nordyke, T. S. Reppun, L. D. Madanay, J. C. Woods, A. P. Goldstein, and L. A. Miyamoto Alternative Sequences of Thyrotropin and Free Thyroxine Assays for Routine Thyroid Function Testing: Quality and Cost Arch Intern Med, February 9, 1998; 158(3): 266 - 272. [Abstract] [Full Text] [PDF]

				K. A. Woeber Subclinical Thyroid Dysfunction Arch Intern Med, May 26, 1997; 157(10): 1065 - 1068. [Abstract] [PDF]